Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged &#8804;50 years.

Rafiq, Meena; Abel, Gary; Renzi, Cristina; Lyratzopoulos, Georgios

Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged ≤50 years.

Rafiq, Meena; Abel, Gary; Renzi, Cristina; Lyratzopoulos, Georgios.

Afiliação

Rafiq M; Institute of Epidemiology and Health Care, UCL, London.
Abel G; University of Exeter Medical School, Exeter.
Renzi C; Institute of Epidemiology and Health Care, UCL, London.
Lyratzopoulos G; Institute of Epidemiology and Health Care, UCL, London.

Br J Gen Pract ; 72(721): e546-e555, 2022 08.

Article em En | MEDLINE | ID: mdl-35817582

Assuntos

Doença de Hodgkin; Biomarcadores; Estudos de Casos e Controles; Doença de Hodgkin/diagnóstico; Humanos; Razão de Chances; Atenção Primária à Saúde; Reino Unido/epidemiologia

Palavras-chave

Hodgkin lymphoma; blood tests; diagnostic time window; general practice; inflammatory markers

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Equity_inequality Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Br J Gen Pract Ano de publicação: 2022 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google